Invasive lobular carcinoma (ILC) is the second most common type of breast cancer and is increasingly recognized as a separate entity from invasive breast cancer of no-special type. Here, we present the current standings and challenges of clinical ILC research and discuss possible solutions to address these challenges.
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer
Annals of Oncology | | K. Van Baelen, E. Sawyer, J. Van Cauwenberge, P. Aftimos, M.F. Covington, M. Maetens, G. Zels, C. Brisken, L. Djerroudi, R. Dresen, A. Fitzpatrick, R.L. Flaherty, G. Floris, S. Freeney, A.B. Hanker, D. Honey, C.M. Isacke, R.C. Jankowitz, R. Jeselsohn, T. Koorman, C. Kuhl, S. Linn, C.J. Lord, C. Malhaire, J. Mouabbi, R. Mukhtar, G. Nader-Marta, R. Natrajan, P. Neven, S. Oesterreich, J.L. Sandoval, S.J. Schnitt, E. Senkus, C. Turner, V. Vandecaveye, H. Wildiers, A. Vincent-Salomon, P.W.B. Derksen, C. Desmedt
Topics: breast-cancer, blood-cancer, cervical-cancer, research